Ironwood Pharmaceuticals IRWD Business Segments
| TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | TTM Q3 '24 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Collaborative Arrangement Development And Commercialization Agreements | -$1.68M-34.7% | -$1.25M-161% | $2.03M-9.4% | $2.24M-23.8% | $2.94M-9.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ironwood Pharmaceuticals break its business down?
- Ironwood Pharmaceuticals (IRWD) reports revenue by product across 2 parts — Collaborative Arrangement Development And Commercialization Agreements and Royalty. Each is extracted from the segment footnotes and tracked over time.
- Where does Ironwood Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ironwood Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
